![]() |
![]() |
|||||||||
|
What to expect before and during treatment What are some possible side effects of treatment What kind of special oral diet may be recommended How you may get the most benefit from treatment
|
Zorbtive® [somatropin (rDNA origin) for injection] is taken once daily by injection under the skin (subcutaneously). Zorbtive is what doctors sometimes refer to as a “short-term” treatment, because it is only taken for 28 days. (Note: Treatment for more than 28 days has not been adequately studied.) You, or your caregiver, should be taught how to give the injections. Your doctor will tell you how much Zorbtive to take and may change the dose depending on how you respond. Make sure to read the Patient Leaflet and the Full Prescribing Information for full safety disclosure, treatment and dosing information. Talk to your doctor. Both are available on this web site. More information about Zorbtive treatment is also available by calling SeroCareSM toll free at 800-714-2437. Go to Zorbtive Patient Support to learn more about SeroCare.
What to expect before and during treatment |
|||||||||
|
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional.
This Web site was developed by EMD
Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS
patients This site contains medical information that is intended for residents of the United States © 2007 EMD Serono, Inc. All rights reserved.
|
||||||||||